Dr Rozaleen Dash
Dr Rozaleen Dash
Senior Research Scientist, DBT COE for Biopharmaceutical Technology, IIT Delhi
Verified email at
Cited by
Cited by
Assessment of structural and functional similarity of biosimilar products: rituximab as a case study
N Nupur, N Chhabra, R Dash, AS Rathore
MAbs 10 (1), 143-158, 2018
Impact of mAb aggregation on its biological activity: rituximab as a case study
R Bansal, R Dash, AS Rathore
Journal of Pharmaceutical Sciences 109 (9), 2684-2698, 2020
Structure-based design of small peptide ligands to inhibit early-stage protein aggregation nucleation
A Mishra, R Bansal, S Sreenivasan, R Dash, S Joshi, R Singh, ...
Journal of Chemical Information and Modeling 60 (6), 3304-3314, 2020
A novel piperazine derivative that targets hepatitis B surface antigen effectively inhibits tenofovir resistant hepatitis B virus
S Kiruthika, R Bhat, R Dash, AS Rathore, V Perumal, B Jayaram
Scientific reports 11, 11723, 2021
Assessment of Functional Characterization and Comparability of Biotherapeutics: a Review
R Dash, SK Singh, N Chirmule, AS Rathore
The AAPS Journal 24 (15), 2021
Freeze thaw and lyophilization induced alteration in mAb therapeutics: Trastuzumab as a case study
R Dash, AS Rathore
Journal of Pharmaceutical and Biomedical Analysis 201, 114122, 2021
Complement receptor 2 (CR2/CD21)
R Dash, N Das
Int. J. Res. Med. Sci 5 (1156), 20171, 2017
Real-Time Characterization of Biotherapeutics and Comparability of Biosimilars
AS Rathore, R Dash
Biopharm International 33 (3), 34-39, 2019
Expression and modulation of complement receptor 2 (CR2/CD21) in the pathophysiology of rheumatoid arthritis
R Dash, U Kumar, M Kanjilal, N Das
International Journal of Research in Medical Sciences 4 (8), 3394, 2016
Study on awareness regardin g gender based violence among group D workers in public hospitals of Delhi, India: a gender perspective
MM Singh, S Garg, R Dash, R Kumar, N Jain, N Sharma, T Anand
International Journal of Community Medicine and Public Health 3 (6), 1510, 2016
An efficient computational protocol for template‐based design of peptides that inhibit interactions involving SARS‐CoV‐2 proteins
A Chenna, WH Khan, R Dash, S Saraswat, A Chugh, AS Rathore, G Goel
Proteins: Structure, Function, and Bioinformatics 91 (9), 1222-1234, 2023
Late-Stage Failures of Monoclonal Antibodies
AS Rathore, R Dash
Template-based design of peptides to inhibit SARS-CoV-2 RNA-dependent RNA polymerase complexation
A Chenna, WH Khan, R Dash, AS Rathore, G Goel
bioRxiv, 2022.01. 24.477502, 2022
Emergence of India as a Global Manufacturing Hub for Biosimilars
AS Rathore, S Joshi, R Dash, N Nupur, S Shravan
BioPharm International 34 (11), 42-44, 2021
Strengthening role of health sectors in gender based violence
R Dash, MM Singh
Int J Community Med Public Heal 3 (6), 1341-7, 2016
Current status and future prospective of breast cancer immunotherapy.
AS Rathore, N Chirmule, R Dash, A Chowdhury
Advances in Protein Chemistry and Structural Biology 140, 293-326, 2024
Mathematical Modeling of Cell-based Potency Data for mAb Biotherapeutics
R Dash, S Mandal, AS Rathore
BioPharm International, 2022
Late-Stage Failures of Monoclonal Antibody Biotherapeutics
AS Rathore, R Dash
Biopharm International, 2021
Tools for Functional Assessment of Biotherapeutics
AS Rathore, R Dash, R Jain, J Auclair
LC GC North America 39 (6), 28, 2021
Characterizing Biotherapeutics and Determining Biosimilar Comparability
A Rathore, R Dash
In the Lab eNewsletter 14 (4), 2019
The system can't perform the operation now. Try again later.
Articles 1–20